Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: ‘Clinical Consequences of the New MASLD Nomenclature‘ with guest speaker Prof. Maja Thiele.
During this webinar, our speaker and hosts dived into the following topics:
- Is the MASLD nomeclature of prognostic relevance?
- Do we need to re-validate all NILTs after the new nomenclature?
- Considerations for “the new kid in town”: MetALD
Speakers, hosts, and audience
- Speaker: Prof. Maja Thiele
- Hosts: Prof. Manuel Castro Cabezas & Prof. Christophe Moreno
- Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers
You can watch the replay here: https://vimeo.com/973037860
Â
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
Webinar: Plasma biomarkers for diagnosis and monitoring of neurodegenerative disorders
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...
Webinar: Real-World Data in ALS
On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...